P

Inventor

WAGNER PHILIPP

DE35 patents
⚠️ This page may combine multiple inventors who share the name “WAGNER PHILIPP”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

IMMATICS BIOTECHNOLOGIES GMBH

24 patents
US11278571B2Mar 22, 2022

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH8 citations94
US10888587B2Jan 12, 2021

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH8 citations92
US10881690B2Jan 5, 2021

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH8 citations92
US10869897B2Dec 22, 2020

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH8 citations92
US10722538B2Jul 28, 2020

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH8 citations92
US10639331B2May 5, 2020

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH8 citations92
US10639332B2May 5, 2020

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH8 citations92
US10568909B2Feb 25, 2020

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH8 citations92
US10463696B2Nov 5, 2019

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH11 citations92
US9889159B2Feb 13, 2018

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH16 citations92
US11214608B2Jan 4, 2022

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH6 citations85
US11246889B2Feb 15, 2022

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH5 citations84
US11248035B1Feb 15, 2022

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH3 citations84
US11078253B2Aug 3, 2021

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH5 citations84
US11071756B2Jul 27, 2021

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH5 citations84
US11053296B2Jul 6, 2021

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH5 citations84
US11819518B2Nov 21, 2023

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH1 citations73
US11806366B2Nov 7, 2023

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations73
US12065477B2Aug 20, 2024

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11919940B2Mar 5, 2024

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11858978B2Jan 2, 2024

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11840562B2Dec 12, 2023

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11345737B1May 31, 2022

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US12098183B2Sep 24, 2024

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

IMMATICS BIOTECHNOLOGIES GMBH0 citations60

WAGNER PHILIPP

4 patents

AGRILUTION GMBH

3 patents

X-TOWER CONSTRUCTIONS GMBH

1 patent

MAN TRUCK & BUS AG

1 patent

VILEI SIMONA BERARDI

1 patent

MAN TRUCK & BUS SE

1 patent